ANI Pharmaceuticals - Stock Price History | ANIP

Historical daily share price chart and data for ANI Pharmaceuticals since 2020 adjusted for splits. The latest closing stock price for ANI Pharmaceuticals as of March 27, 2020 is 37.76.
  • The all-time high ANI Pharmaceuticals stock closing price was 449.82 on June 02, 2000.
  • The ANI Pharmaceuticals 52-week high stock price is 86.96, which is 130.3% above the current share price.
  • The ANI Pharmaceuticals 52-week low stock price is 28.28, which is 25.1% below the current share price.
  • The average ANI Pharmaceuticals stock price for the last 52 weeks is 66.62.
ANI Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 67.8473 45.8300 85.3900 45.8300 61.6700 36.98%
2018 59.8584 68.7300 72.4100 41.1700 45.0200 -30.15%
2017 53.5606 61.2700 74.5600 43.4500 64.4500 6.32%
2016 51.7281 44.0700 69.9500 28.0900 60.6200 34.34%
2015 54.9820 56.9900 71.7800 37.3400 45.1250 -19.98%
2014 33.0723 19.2700 60.2100 18.8300 56.3900 180.83%
2013 8.7853 7.8584 20.1100 5.3689 20.0800 172.14%
2012 15.3516 17.3954 37.7849 6.8386 7.3785 -59.16%
2011 83.8395 59.7361 137.1052 13.6745 18.0684 -69.38%
2010 60.7572 55.7777 87.8049 47.1411 59.0164 13.10%
2009 63.2147 42.4630 93.2027 41.0236 52.1791 45.00%
2008 134.4013 131.3475 204.7581 30.5878 35.9856 -73.54%
2007 192.0341 100.7597 276.3694 97.8808 136.0256 36.46%
2006 104.8772 126.3095 168.7725 55.7777 99.6801 -24.11%
2005 147.2497 184.6062 213.7545 101.1195 131.3475 -33.39%
2004 243.1970 146.8213 375.6897 146.8213 197.2011 32.37%
2003 102.4190 118.7525 159.4162 66.5734 148.9804 23.58%
2002 156.9986 269.8920 269.8920 71.9712 120.5518 -60.59%
2001 254.3950 269.8920 377.8488 136.7453 305.8776 13.33%
2000 289.4023 212.3151 449.8201 172.7309 269.8920 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.457B $0.207B
ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture and metoclopramide tablets. In addition, it offers contract manufacturing services for other pharmaceutical companies. The company serves through wholesalers, smaller regional distributors and chains and pharmacy and retail outlets primarily in the United States. ANI Pharmaceuticals, Inc., formerly known as BioSante Pharmaceuticals, Inc., is headquartered in Baudette, MN.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.941B 13.37
Gilead Sciences (GILD) United States $91.719B 11.86
CSL (CSLLY) Australia $79.295B 0.00
Vertex Pharmaceuticals (VRTX) United States $56.324B 51.12
Biogen (BIIB) United States $51.654B 8.82
Regeneron Pharmaceuticals (REGN) United States $49.455B 20.95
Illumina (ILMN) United States $39.550B 40.89
Seattle Genetics (SGEN) United States $18.823B 0.00
Alexion Pharmaceuticals (ALXN) United States $18.600B 8.65
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.120B 0.00
Incyte (INCY) United States $14.949B 32.07
BioMarin Pharmaceutical (BMRN) United States $14.306B 611.61
Genmab (GNMSF) Denmark $12.862B 41.37
BioNTech SE (BNTX) Germany $12.444B 0.00
Alnylam Pharmaceuticals (ALNY) United States $11.782B 0.00
Galapagos (GLPG) Belgium $11.779B 25.73
Bio-Rad Laboratories (BIO.B) United States $9.935B 46.43
Moderna (MRNA) United States $9.887B 0.00
QIAGEN (QGEN) Netherlands $9.213B 28.09
Exact Sciences (EXAS) United States $8.567B 0.00
BeiGene (BGNE) Cayman Islands $8.176B 0.00
Sarepta Therapeutics (SRPT) United States $7.345B 0.00
Bio-Techne Corp (TECH) United States $7.072B 48.40
Guardant Health (GH) United States $6.398B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.032B 0.00
Ascendis Pharma (ASND) Denmark $5.414B 0.00
Exelixis (EXEL) United States $5.262B 16.89
Horizon Therapeutics Public (HZNP) Ireland $5.235B 13.83
Reata Pharmaceuticals (RETA) United States $4.984B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.980B 0.00
Repligen (RGEN) United States $4.820B 88.14
Amarin (AMRN) Ireland $4.730B 0.00
Acceleron Pharma (XLRN) United States $4.643B 0.00
China Biologic Products (CBPO) China $4.279B 25.40
Vir Biotechnology (VIR) United States $3.762B 0.00
MorphoSys AG (MOR) Germany $3.364B 0.00
Mirati Therapeutics (MRTX) United States $3.318B 0.00
Adaptive Biotechnologies (ADPT) United States $3.206B 0.00
Blueprint Medicines (BPMC) United States $3.140B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.130B 0.00
Global Blood Therapeutics (GBT) United States $3.110B 0.00
Zai Lab (ZLAB) China $2.961B 0.00
Immunomedics (IMMU) United States $2.747B 0.00
NeoGenomics (NEO) United States $2.695B 116.86
Emergent Biosolutions (EBS) United States $2.663B 18.49
Bluebird Bio (BLUE) United States $2.657B 0.00
Genmab (GMAB) Denmark $2.588B 10.15
CRISPR Therapeutics AG (CRSP) Switzerland $2.545B 43.11
MyoKardia (MYOK) United States $2.488B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.452B 0.00
Halozyme Therapeutics (HALO) United States $2.416B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.329B 0.00
Amicus Therapeutics (FOLD) United States $2.300B 0.00
Alkermes (ALKS) Ireland $2.272B 180.00
Arena Pharmaceuticals (ARNA) United States $2.238B 5.83
RA PHARMCTL INC (RARX) United States $2.220B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.138B 0.00
Denali Therapeutics (DNLI) United States $1.995B 0.00
UniQure (QURE) Netherlands $1.959B 0.00
Epizyme (EPZM) United States $1.792B 0.00
Alector (ALEC) United States $1.787B 0.00
Viela Bio (VIE) United States $1.769B 0.00
Fate Therapeutics (FATE) United States $1.684B 0.00
Principia Biopharma (PRNB) United States $1.673B 0.00
Eidos Therapeutics (EIDX) United States $1.618B 0.00
Insmed (INSM) United States $1.541B 0.00
Arvinas (ARVN) United States $1.538B 0.00
Zymeworks (ZYME) Canada $1.470B 0.00
Akcea Therapeutics (AKCA) United States $1.345B 28.93
Dicerna Pharmaceuticals (DRNA) United States $1.263B 0.00
REGENXBIO (RGNX) United States $1.258B 0.00
Inovio Pharmaceuticals (INO) United States $1.213B 0.00
Coherus BioSciences (CHRS) United States $1.148B 13.66
Ligand Pharmaceuticals (LGND) United States $1.102B 34.25
Editas Medicine (EDIT) United States $1.095B 0.00
Twist Bioscience (TWST) United States $1.063B 0.00
Zealand Pharma (ZEAL) Denmark $1.054B 0.00
Myriad Genetics (MYGN) United States $1.048B 18.50
NextCure (NXTC) United States $1.007B 0.00
PHARMA MAR SA (PHMMF) Spain $0.983B 0.00
Adverum Biotechnologies (ADVM) United States $0.911B 0.00
Revance Therapeutics (RVNC) United States $0.887B 0.00
NGM Biopharmaceuticals (NGM) United States $0.886B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Intra-Cellular Therapies (ITCI) United States $0.877B 0.00
Sangamo Therapeutics (SGMO) United States $0.737B 0.00
Cytokineticsorporated (CYTK) United States $0.699B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.680B 0.00
Novavax (NVAX) United States $0.672B 0.00
Kadmon Holdings (KDMN) United States $0.637B 0.00
Athenex (ATNX) United States $0.615B 0.00
Pharming Group (PHGUF) Netherlands $0.613B 0.00
Frequency Therapeutics (FREQ) United States $0.609B 0.00
Codexis (CDXS) United States $0.607B 0.00
Retrophin (RTRX) United States $0.594B 0.00
Cara Therapeutics (CARA) United States $0.589B 0.00
Intellia Therapeutics (NTLA) United States $0.583B 0.00
Arcus Biosciences (RCUS) United States $0.582B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.582B 0.00
Bellus Health (BLU) Canada $0.554B 0.00
GENFIT S.A (GNFT) France $0.552B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.537B 0.00
Intrexon (PGEN) United States $0.533B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.528B 0.00
Clovis Oncology (CLVS) United States $0.524B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.491B 4.32
Compugen (CGEN) Israel $0.491B 0.00
Castle Biosciences (CSTL) United States $0.486B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Mesoblast (MESO) Australia $0.435B 0.00
DBV Technologies S.A (DBVT) France $0.434B 0.00
MeiraGTx Holdings (MGTX) United States $0.429B 0.00
AC Immune SA (ACIU) Switzerland $0.429B 9.92
Morphic Holding (MORF) United States $0.427B 0.00
Vericel (VCEL) United States $0.422B 62.60
Heska (HSKA) United States $0.419B 0.00
Anika Therapeutics (ANIK) United States $0.415B 14.29
Aquinox Pharmaceuticals (NLTX) United States $0.405B 0.00
MiMedx (MDXG) United States $0.403B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.400B 0.00
Scholar Rock Holding (SRRK) United States $0.400B 0.00
Verastem (VSTM) United States $0.400B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.398B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.385B 0.00
Prothena (PRTA) Ireland $0.383B 0.00
AnaptysBio (ANAB) United States $0.382B 0.00
Agenus (AGEN) United States $0.380B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.371B 0.00
UROGEN PHARMA (URGN) United States $0.370B 0.00
Cellectis S.A (CLLS) France $0.365B 0.00
Merus (MRUS) Netherlands $0.360B 0.00
Cue Biopharma (CUE) United States $0.352B 0.00
BioDelivery Sciences (BDSI) United States $0.340B 39.22
Puma Biotechnology (PBYI) United States $0.338B 0.00
PDL BioPharma (PDLI) United States $0.336B 10.07
Sorrento Therapeutics (SRNE) United States $0.328B 0.00
Athersys (ATHX) United States $0.322B 0.00
WAVE Life Sciences (WVE) Singapore $0.319B 0.00
Precision BioSciences (DTIL) United States $0.318B 0.00
NantKwest (NK) United States $0.310B 0.00
Dynavax Technologies (DVAX) United States $0.307B 0.00
Cellular Biomedicine (CBMG) United States $0.297B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.292B 0.00
CytomX Therapeutics (CTMX) United States $0.289B 0.00
Mersana Therapeutics (MRSN) United States $0.287B 0.00
Kala Pharmaceuticals (KALA) United States $0.285B 0.00
ADMA Biologics Inc (ADMA) United States $0.265B 0.00
Avid Bioservices (CDMO) United States $0.264B 0.00
Albireo Pharma (ALBO) United States $0.248B 0.00
Kamada (KMDA) Israel $0.244B 10.17
Seres Therapeutics (MCRB) United States $0.244B 0.00
Alcobra (ARCT) United States $0.239B 0.00
Sutro Biopharma (STRO) United States $0.226B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.226B 0.00
MannKind (MNKD) United States $0.225B 0.00
Stemline Therapeutics (STML) United States $0.222B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.218B 0.00
Syros Pharmaceuticals (SYRS) United States $0.218B 0.00
Geron (GERN) United States $0.214B 0.00
Aduro Biotech (ADRO) United States $0.206B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.204B 0.00
Gritstone Oncology (GRTS) United States $0.202B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.193B 1.73
XOMA (XOMA) United States $0.185B 0.00
Selecta Biosciences (SELB) United States $0.183B 0.00
ChromaDex (CDXC) United States $0.176B 0.00
OSMOTICA PHARM (OSMT) United States $0.176B 0.00
Protagonist Therapeutics (PTGX) United States $0.175B 0.00
HOOKIPA Pharma (HOOK) United States $0.173B 0.00
IVERIC Bio (ISEE) United States $0.172B 0.00
Abeona Therapeutics (ABEO) United States $0.172B 0.00
Starpharma Holdings (SPHRY) Australia $0.168B 0.00
VBI Vaccines (VBIV) United States $0.166B 0.00
Aytu Bioscience (AYTU) United States $0.166B 0.00
Prometic Life Sciences (LMNL) Canada $0.160B 0.00
Kindred Biosciences (KIN) United States $0.160B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Spero Therapeutics (SPRO) United States $0.158B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.152B 0.00
POXEL SA FRANCE (PXXLF) France $0.145B 0.00
Windtree Therapeutics (WINT) United States $0.144B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.137B 0.00
Cerecor (CERC) United States $0.136B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.135B 0.00
Fortress Biotech (FBIO) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Liquidia Technologies (LQDA) United States $0.132B 0.00
VTv Therapeutics (VTVT) United States $0.132B 0.00
Dyadic (DYAI) United States $0.122B 0.00
Antibe Therapeutics (ATBPF) Canada $0.121B 0.00
Affimed (AFMD) Germany $0.119B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.118B 0.00
Theratechnologies (THTX) Canada $0.118B 0.00
Enzo Biochem (ENZ) United States $0.117B 0.00
Exicure (XCUR) United States $0.115B 0.00
Celyad SA (CYAD) Belgium $0.113B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.110B 0.00
AIT Therapeutics (XAIR) United States $0.104B 0.00
Northwest Biotherapeutics (NWBO) United States $0.102B 0.00
Strongbridge Biopharma (SBBP) United States $0.101B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
PHASEBIO PHARMA (PHAS) United States $0.096B 0.00
Aptinyx (APTX) United States $0.095B 0.00
TELA Bio (TELA) United States $0.091B 0.00
OvaScience (MLND) United States $0.088B 0.00
Checkpoint Therapeutics (CKPT) United States $0.086B 0.00
ARAVIVE, INC (ARAV) United States $0.086B 0.00
Five Prime Therapeutics (FPRX) United States $0.085B 0.00
Cyclerion Therapeutics (CYCN) United States $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.083B 0.00
Clearside Biomedical (CLSD) United States $0.078B 0.00
Eton Pharmaceuticals (ETON) United States $0.078B 0.00
Happiness Biotech Group (HAPP) China $0.075B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
Menlo Therapeutics (MNLO) United States $0.070B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.069B 0.00
Proteostasis Therapeutics (PTI) United States $0.067B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
Adocia (ADOCY) France $0.066B 0.00
Emmaus Life Sciences (EMMA) United States $0.064B 0.00
SESEN BIO, INC (SESN) United States $0.062B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
Orgenesis (ORGS) United States $0.061B 3.55
Synlogic (SYBX) United States $0.060B 0.00
AquaBounty Technologies (AQB) United States $0.059B 0.00
Catalyst Biosciences (CBIO) United States $0.057B 0.00
Trevena (TRVN) United States $0.056B 0.00
Pluristem Therapeutics (PSTI) Israel $0.054B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.052B 0.00
Acorda Therapeutics (ACOR) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Idera Pharmaceuticals (IDRA) United States $0.043B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Soligenix (SNGX) United States $0.038B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.036B 0.00
Lumos Pharma (LUMO) United States $0.036B 0.00
Advaxis (ADXS) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
CollPlant Holdings (CLGN) Israel $0.034B 0.00
TOCAGEN INC (TOCA) United States $0.031B 0.00
Celldex Therapeutics (CLDX) United States $0.030B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.028B 0.00
Prima BioMed (IMMP) Australia $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Entera Bio (ENTX) Israel $0.027B 0.00
Signal Genetics (MGEN) United States $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
VistaGen Therapeutics (VTGN) United States $0.023B 0.00
Pulmatrix (PULM) United States $0.023B 0.00
Alimera Sciences (ALIM) United States $0.022B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Celsion (CLSN) United States $0.020B 0.00
Stellar Biotechnologies (EDSA) Canada $0.019B 0.00
BioCardia (BCDA) United States $0.019B 0.00
Oncobiologics (OTLK) United States $0.019B 0.00
Apricus Biosciences (SEEL) United States $0.018B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.014B 0.00
AEterna Zentaris (AEZS) United States $0.013B 0.00
Aptevo Therapeutics (APVO) United States $0.013B 0.00
ATyr Pharma (LIFE) United States $0.013B 0.00
TrovaGene (TROV) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
VIVUS (VVUS) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00